We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$470M
AUM Growth
+$139M
Cap. Flow
+$65.1M
Cap. Flow %
13.84%
Top 10 Hldgs %
19.08%
Holding
192
New
61
Increased
56
Reduced
39
Closed
32

Top Buys

Rank Stock Value
1
SF
Stifel
SF
+$10.7M
2
WTFC icon
Wintrust Financial
WTFC
+$7.02M
3
WD icon
Walker & Dunlop
WD
+$7.01M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$6.32M
5
MZTI
The Marzetti Company
MZTI
+$5.79M

Top Sells

Rank Stock Value
1
EXPO icon
Exponent
EXPO
+$8.07M
2
FIVN icon
FIVE9
FIVN
+$6.07M
3
RGEN icon
Repligen
RGEN
+$5.56M
4
CSFL
CenterState Bank Corporation Common Stock
CSFL
+$5.52M
5
MRCY icon
Mercury Systems
MRCY
+$5.46M

Sector Composition

Rank Sector Weight
1 Financials 19.01%
2 Technology 15.3%
3 Industrials 15.08%
4 Healthcare 12.49%
5 Consumer Discretionary 12.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXSM icon
76
Axsome Therapeutics
AXSM
$10.9B
$2.48M 0.53%
30,176
-32,030
-51% -$2.47M
DRNA
77
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.38M 0.51%
93,668
+13,826
+17% +$298K
ACAD icon
78
Acadia Pharmaceuticals
ACAD
$5.03B
$2.28M 0.48%
47,035
-73,181
-61% -$3.51M
SITE icon
79
SiteOne Landscape Supply
SITE
$4.53B
$2.25M 0.48%
+19,739
New +$1.83M
QTRX icon
80
Quanterix
QTRX
$190M
$2.24M 0.48%
+81,702
New +$2.06M
KYNB
81
Kyntra Bio
KYNB
$29.4M
$2.19M 0.47%
2,160
+305
+16% +$283K
HELE icon
82
Helen of Troy
HELE
$693M
$2.15M 0.46%
+11,427
New +$1.87M
FIX icon
83
Comfort Systems
FIX
$59.6B
$2.15M 0.46%
52,691
+7,688
+17% +$273K
MYOK
84
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$2.1M 0.45%
+21,679
New +$1.81M
NVAX icon
85
Novavax
NVAX
$1.31B
$2.06M 0.44%
+24,657
New +$943K
CNMD icon
86
CONMED
CNMD
$1.47B
$2M 0.43%
27,799
+4,079
+17% +$284K
IOVA icon
87
Iovance Biotherapeutics
IOVA
$2.83B
$1.78M 0.38%
64,755
-20,030
-24% -$658K
CPRI icon
88
Capri Holdings
CPRI
$1.74B
$1.72M 0.36%
+109,713
New +$1.62M
EHTH icon
89
eHealth
EHTH
$43.9M
$1.63M 0.35%
16,586
-17,822
-52% -$2.07M
MNTA
90
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.57M 0.33%
47,190
+6,965
+17% +$222K
IGMS
91
DELISTED
IGM Biosciences
IGMS
$1.38M 0.29%
+18,873
New +$1.15M
ALLY icon
92
Ally Financial
ALLY
$13.3B
$1.33M 0.28%
+66,899
New +$1.14M
RETA
93
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.32M 0.28%
8,481
+1,130
+15% +$172K
VIVO
94
DELISTED
Meridian Bioscience Inc
VIVO
$1.29M 0.27%
+55,210
New +$800K
FL
95
DELISTED
Foot Locker
FL
$1.25M 0.27%
+42,977
New +$1.13M
THG icon
96
Hanover Insurance
THG
$7.98B
$1.25M 0.27%
12,351
+3,475
+39% +$341K
RHI icon
97
Robert Half
RHI
$4.37B
$1.24M 0.26%
23,549
-4,247
-15% -$202K
KSS icon
98
Kohl's
KSS
$2.19B
$1.24M 0.26%
+59,494
New +$1.15M
RS icon
99
Reliance Steel & Aluminium
RS
$21.6B
$1.21M 0.26%
12,709
-2,240
-15% -$204K
AB icon
100
AllianceBernstein
AB
$3.47B
$1.18M 0.25%
43,327
+8,040
+23% +$186K
2 3
4
5 6

Similar funds

CAM
Cander Asset Management New York $557M AUM
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return
CFP
Curran Financial Partners Daniel Island, South Carolina $559M AUM 13.69% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return

Moody Aldrich Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Moody Aldrich Partners held 192 positions worth $470M, up 42% from $331M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Moody Aldrich Partners deployed $65.1M of net new capital in Q2 2020, opening 61 new positions and adding to 56 existing holdings. Its largest new stake was Stifel: 533,720 shares worth $11.3M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Repligen, an estimated $5.56M trimmed.

  • Moody Aldrich Partners's largest Q2 2020 buy was Stifel: 533,720 shares worth $11.3M.
  • Moody Aldrich Partners added most to US Ecology, Inc. in Q2 2020, an estimated $3.84M increase.
  • Moody Aldrich Partners's biggest Q2 2020 reduction was Repligen, cutting an estimated $5.56M.
  • Moody Aldrich Partners fully exited Exponent in Q2 2020, selling an estimated $8.07M.
  • Moody Aldrich Partners's ten largest holdings make up 19% of its $470M portfolio in Q2 2020.
  • Moody Aldrich Partners opened 61 new positions and closed 32 in Q2 2020.
  • Moody Aldrich Partners's portfolio value rose 42% quarter-over-quarter to $470M.

Based on Moody Aldrich Partners's 13F filing for Q2 2020, filed 30 Jul 2020.